StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)

Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%

Cvs Health r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Cvs Health

Cvs Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cvs Health figures

See a number that looks wrong?